CAD 0.01
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -2.59 Million USD | 99.94% |
2022 | -25.02 Million USD | -247.82% |
2021 | 7.95 Million USD | 175.23% |
2020 | -22.5 Million USD | 55.76% |
2019 | -267.16 Million USD | -101.09% |
2018 | -25.29 Million USD | -232.01% |
2017 | -7.61 Million USD | -69.26% |
2016 | -4.5 Million USD | -242.12% |
2015 | - USD | -123560.53% |
2014 | -1064.00 USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 9.14 Million USD | 347.72% |
2024 Q1 | 2.63 Million USD | 153.03% |
2023 FY | - USD | 99.94% |
2023 Q4 | -3.44 Million USD | -218.15% |
2023 Q3 | 2.91 Million USD | 77.25% |
2023 Q2 | 1.64 Million USD | 231.0% |
2023 Q1 | -1.25 Million USD | 73.37% |
2022 Q3 | -5.48 Million USD | 78.45% |
2022 FY | - USD | -247.82% |
2022 Q1 | 10.62 Million USD | 471.75% |
2022 Q4 | -4.71 Million USD | 14.08% |
2022 Q2 | -25.45 Million USD | -339.62% |
2021 Q3 | 3.54 Million USD | -65.37% |
2021 FY | - USD | 175.23% |
2021 Q2 | 10.22 Million USD | 69.9% |
2021 Q1 | 6.01 Million USD | 123.69% |
2021 Q4 | -2.85 Million USD | -180.68% |
2020 FY | - USD | 55.76% |
2020 Q3 | 23.96 Million USD | 3012.86% |
2020 Q2 | 770 Thousand USD | 108.25% |
2020 Q4 | -25.41 Million USD | -206.02% |
2020 Q1 | -9.32 Million USD | 3.53% |
2019 Q4 | -9.67 Million USD | 32.72% |
2019 Q2 | -17.02 Million USD | -73.62% |
2019 Q3 | -14.37 Million USD | 15.57% |
2019 FY | - USD | -101.09% |
2019 Q1 | -9.8 Million USD | -12.24% |
2018 FY | - USD | -232.01% |
2018 Q4 | -8.73 Million USD | -67.41% |
2018 Q3 | -5.21 Million USD | 33.24% |
2018 Q2 | -7.81 Million USD | -121.44% |
2018 Q1 | -3.52 Million USD | -16.56% |
2017 Q3 | -1.55 Million USD | 0.38% |
2017 Q1 | -1.47 Million USD | -8.36% |
2017 Q2 | -1.56 Million USD | -6.31% |
2017 FY | - USD | -69.26% |
2017 Q4 | -3.02 Million USD | -94.41% |
2016 Q1 | -530.1 Thousand USD | 25.06% |
2016 Q4 | -1.35 Million USD | 23.71% |
2016 FY | - USD | -242.12% |
2016 Q3 | -1.77 Million USD | -18761.87% |
2016 Q2 | -9432.00 USD | 98.22% |
2015 Q3 | -200.53 Thousand USD | -2190.55% |
2015 Q2 | -8755.00 USD | 0.0% |
2015 Q4 | -707.37 Thousand USD | -252.74% |
2015 FY | - USD | -123560.53% |
2014 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aion Therapeutic Inc. | -6.07 Million CAD | 57.308% |
Ayurcann Holdings Corp. | -2.01 Million CAD | -28.973% |
Blueberries Medical Corp. | -1.22 Million CAD | -112.23% |
The BC Bud Corporation | -1.19 Million CAD | -116.803% |
BioNxt Solutions Inc. | -6.48 Million CAD | 60.013% |
CordovaCann Corp. | -1.6 Million CAD | -61.798% |
Christina Lake Cannabis Corp. | -2.62 Million CAD | 1.161% |
Captor Capital Corp. | 2.42 Million CAD | 207.097% |
City View Green Holdings Inc. | -2.01 Million CAD | -28.719% |
1CM Inc. | 1.31 Million CAD | 297.408% |
Global Hemp Group Inc. | -24.79 Thousand CAD | -10358.597% |
Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -17.416% |
IM Cannabis Corp. | -2.79 Million CAD | 7.061% |
Lobe Sciences Ltd. | -4.4 Million CAD | 41.099% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | -561.115% |
Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 18.791% |
Nextleaf Solutions Ltd. | 1.14 Million CAD | 327.137% |
Ovation Science Inc. | -778.83 Thousand CAD | -232.934% |
Pharmadrug Inc. | -1.33 Million CAD | -94.23% |
Captiva Verde Wellness Corp. | -6.05 Million CAD | 57.184% |
RAMM Pharma Corp. | -6.3 Million CAD | 58.855% |
RIV Capital Inc. | -20.28 Million CAD | 87.214% |
Revive Therapeutics Ltd. | -5.59 Million CAD | 53.655% |
Red White & Bloom Brands Inc. | -77.59 Million CAD | 96.658% |
SLANG Worldwide Inc. | -2.95 Million CAD | 12.123% |
1933 Industries Inc. | -10.03 Million CAD | 74.155% |
Red Light Holland Corp. | -5.25 Million CAD | 50.665% |
Top Strike Resources Corp. | -767.99 Thousand CAD | -237.633% |
Xebra Brands Ltd. | -1.49 Million CAD | -73.445% |
Adastra Holdings Ltd. | -1.41 Million CAD | -83.736% |